Is BMY a buy today?

No, in September 2021, BMY stock isn’t a buy.

What did Bristol Myers Stock close at?

$76.59
$ 76.70

Close Chg Chg %
$76.59 1.34 1.78%

What is BMY known for?

Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis, and psychiatric disorders.

How much is Bristol Myers?

Performance Outlook

Previous Close 75.07
Bid 74.77 x 2200
Ask 75.12 x 800
Day’s Range 74.31 – 75.32
52 Week Range 53.22 – 78.61

Is Bristol Myers a buy Zacks?

Zacks’ proprietary data indicates that Bristol Myers Squibb Company is currently rated as a Zacks Rank 3 and we are expecting an inline return from the BMY shares relative to the market in the next few months.

Is BMY a good company?

Great company, bottom tier compensation Benefits and culture are top of the top. Unlike peer, top-tier pharma companies, they are requiring a 50% return to workplace following covid, despite frequent mentions of success & efficiency while working remotely. Pay is absolutely bottom tier with no room for negotiation.

How is working at BMS?

Great company, bottom tier compensation Great place to learn, grow, and begin a career. Benefits and culture are top of the top. Unlike peer, top-tier pharma companies, they are requiring a 50% return to workplace following covid, despite frequent mentions of success & efficiency while working remotely.

Is BMS a biopharmaceutical company?

We are a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Bristol Myers Squibb is committed to patient care and is constantly working to shape the future of cancer care and improve the lives of cancer patients.